Clinical Trial Update: A Study of AZD8233 in Participants With Dyslipidemia. [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study of AZD8233 in participants with dyslipidemia has completed, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• AZD8233

Snippet

Sponsor: AstraZeneca | Conditions: Dyslipidemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-12-24